Anti-CALLA [SS2/36] mAb

Cat. #151348

Anti-CALLA [SS2/36] mAb

Cat. #: 151348

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Common Acute Lymphocytic Leukaemia Antigen (CALLA, CD10)

Class: Monoclonal

Application: FACS ; IHC ; WB

Reactivity: Human

Host: Mouse


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Inventor: Jacqueline Cordell

Institute: University of Oxford

Tool Details
Target Details

Tool Details


  • Name: Anti-CALLA [SS2/36] mAb
  • Clone: SS2/36
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; WB
  • Description: SS2/36 is a marker for Acute Lymphocytic Luekaemia (ALL).
  • Immunogen: Common acute lymphoblastic leukaemia cells
  • Isotype: IgG1
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Common Acute Lymphocytic Leukaemia Antigen (CALLA, CD10)
  • Target background: CALLA is expressed on B- and T- cell precursors, bone marrow stromal cells, lymphoblastic, Burkitt's, and follicular germinal center lymphomas, and on cells from patients with chronic myelocytic leukemia (CML). CALLA is a cell surface enzyme that inactivates a variety of peptides. CALLA is widely used for identification of "common" type Acute Lymphocytic Leukaemia (ALL).


  • Application: FACS ; IHC ; WB


  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C


  • Majdic O, Sugita K, Stockinger H, Skrobal A, Knapp W (1987) Comparative evaluation of CD10 antibodies. In McMichael AJ, et al (eds) Leucocyte Typing III, Oxford University Press, Oxford, New York and Tokyo, p 488-9.